Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
| UAPSX Fund | USD 52.80 0.49 0.92% |
Slightly above 62% of Ultrasmall Cap's investor base is looking to short. The analysis of overall sentiment of trading Ultrasmall Cap Profund Ultrasmall Cap mutual fund suggests that many investors are alarmed at this time. Ultrasmall Cap's investing sentiment can be driven by a variety of factors including economic data, Ultrasmall Cap's earnings reports, geopolitical events, and overall market trends.
Ultrasmall |
PARIS - French healthcare company Sanofi has agreed to buy the drug development project INBRX-101 from its parent company Inhibrx Inc for around 2.2 billion, the companies said on Tuesday. As part of...
Read at streetinsider.com
 |
Ultrasmall Cap Fundamental Analysis
We analyze Ultrasmall Cap's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ultrasmall Cap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ultrasmall Cap based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Ultrasmall Cap is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Ultrasmall Cap Profund Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ultrasmall Cap mutual fund to make a market-neutral strategy. Peer analysis of Ultrasmall Cap could also be used in its relative valuation, which is a method of valuing Ultrasmall Cap by comparing valuation metrics with similar companies.
Peers
Ultrasmall Cap Related Equities
| SRPSX | Short Real | 1.79 | ||||
| SRPIX | Short Real | 1.64 | ||||
| UIPIX | Ultrashort Mid | 0.46 | ||||
| UIPSX | Ultrashort Mid | 0.45 | ||||
| BRPSX | Bear Profund | 0.1 | ||||
| LGPIX | Large Cap | 0.09 | ||||
| BRPIX | Bear Profund | 0.09 | ||||
| LGPSX | Profunds Large | 0.09 | ||||
| TEPIX | Technology Ultrasector | 0.02 | ||||
| TEPSX | Technology Ultrasector | 4.77 |
Other Information on Investing in Ultrasmall Mutual Fund
Ultrasmall Cap financial ratios help investors to determine whether Ultrasmall Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ultrasmall with respect to the benefits of owning Ultrasmall Cap security.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |